Deep Genomics is using artificial intelligence to build a new universe of life-saving genetic therapies. The future of medicine will rely on artificial intelligence, because biology is too complex for humans to understand. At Deep Genomics, our geneticists, molecular biologists and chemists develop new ways of detecting and treating disease using our biologically accurate artificial intelligence technology.
Total Funding: $56.7M
Funding Stage: Series B
Business Stage: Growth
Market: B2C, B2B
Company Size: 26 to 50
Founded: 2014
